BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS

Glioblastoma (GBM) is a common deadly malignant brain cancer of the central nervous system, with a median survival of 12–15 months. Scientific advancements are lacking in developing effective therapies for both primary GBM, as well as secondary GBMs, that typically originate as malignant transformat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajani, Karishma, Carlstrom, Lucas, Jacobs, Joshua, Schroeder, Mark, Olson, Ian, Hainy, Matthew, Oh, Juhee, Elmquist, William, Sarkaria, Jann, Burns, Terry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994322/
http://dx.doi.org/10.1093/noajnl/vdab024.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994322/
http://dx.doi.org/10.1093/noajnl/vdab024.019

Ejemplares similares